INS and type 2 diabetes mellitus: In healthy patients with both type 1 and type 2 diabetes, insulin infusion (with dextrose to maintain euglycemia) leads to decreased reactive oxygen species, systemic cytokine gene expression and serum CRP levels [30–32].